免疫球蛋白G,Fab片段,人血浆

np001071-250μg

250μg

≥95%(SDS-PAGE)

分离的fab片段可用于在溶液中或细胞表面将抗原与抗体结合，而不会分别引起交联和沉淀或“修补”和“封盖”等不希望的并发症。 由经美国食品药品监督管理局要求的测试显示对HBsAg、抗-HCV、抗-HBc无反应且对抗-HIV 1和2呈阴性的血浆制备。 产品引用： Franco, Andrea, et al. "Human Fc Receptor–Like 5 Binds Intact IgG via Mechanisms Distinct from Those of Fc Receptors."The Journal of Immunology 190, no. 11 (2013): 5739-5746. Cattepoel, Susann, et al. "Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro." PloS one 8, no. 5 (2013): e63162. Patel, Ashaben, et. al. "A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation." Journal of Microencapsulation 0 (2014): 1-9. Padmanabhan A, et al. Intravenous immunoglobulin for the treatment of severe refractory heparin induced thrombocytopenia. Chest, Available online 17 April 2017 in press, corrected proof. Fletcher NA, Babcock LR, Murray EA, Krebs MD. Controlled delivery of antibodies from injectable hydrogels. Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:801-806. doi: 10.1016/ j.msec.2015.10.096. Epub 2015 Oct 30. Ref: Ricardo, M. J. et al. 1984. Clinical Diagnosis and Management by Laboratory Methods (J.B. Henry, ed.), 860; Poljak, R.J. 1985. Methods Enzymol. 116, 190. Isolated fab fragments can be used to bind antigen to antibody in solution or on the cell surface without causing the undesired complications of cross-linking and precipitation, or "patching" and capping," respectively. Prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA-required tests. Product Citations: Franco, Andrea, et al. "Human Fc Receptor–Like 5 Binds Intact IgG via Mechanisms Distinct from Those of Fc Receptors."The Journal of Immunology 190, no. 11 (2013): 5739-5746. Cattepoel, Susann, et al. "Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro." PloS one 8, no. 5 (2013): e63162. Patel, Ashaben, et. al. "A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation." Journal of Microencapsulation 0 (2014): 1-9. Padmanabhan A, et al. Intravenous immunoglobulin for the treatment of severe refractory heparin induced thrombocytopenia. Chest, Available online 17 April 2017 in press, corrected proof. Fletcher NA, Babcock LR, Murray EA, Krebs MD. Controlled delivery of antibodies from injectable hydrogels. Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:801-806. doi: 10.1016/ j.msec.2015.10.096. Epub 2015 Oct 30. Ref: Ricardo, M. J. et al. 1984. Clinical Diagnosis and Management by Laboratory Methods (J.B. Henry, ed.), 860; Poljak, R.J. 1985. Methods Enzymol. 116, 190.

50000